Sun Pharmaceutical Industries Ltd.: Drug Recall
Recall #D-0569-2023 · 04/19/2023
Class II: Risk
Recall Details
- Recall Number
- D-0569-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Sun Pharmaceutical Industries Ltd.
- Status
- Terminated
- Date Initiated
- 04/19/2023
- Location
- Halol, N/A, India
- Voluntary/Mandated
- N/A
- Product Quantity
- 24194 Prefilled Syringes
Reason for Recall
Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.
Product Description
Fyremadel (ganirelix acetate) injection, 250 mcg/0.5 mL, One Single Dose Sterile Prefilled Syringe 0.5 mL, For Subcutaneous Use, Rx Only, Sterile, Distributor: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054, USA, NDC 55566-1010-1
Distribution Pattern
Nationwide in the USA
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.